Pretrial proceedings in federal lawsuits against Johnson & Johnson over the DePuy ASR XL Acetabular System recall have been consolidated and will be overseen by a federal judge in Ohio, according to a Bloomberg Businessweek news report.
The hip replacement system was recalled on Aug. 26, 2010 after it was found that the metal-on-metal hip replacements didn't work properly. U.S. District Judge David A. Katz in an Ohio federal court will supervise the evidence-gathering efforts. About 150 federal lawsuits are pending and will be consolidated to promote efficient conduct of litigation, according to the report.
DePuy recalled the ASR XL Acetabular System, a total hip-replacement product, and the DePuy ASR Hip Resurfacing System, which wasn't used in the U.S. Approximately 37,000 ASR implants were implanted in the United States. Researchers in the United Kingdom found that after five years, 13 percent of the patients with complete hip replacements and 12 percent of the patients with resurfacing devices needed a revision.
In a statement released by DePuy, the company will cover reasonable and customary costs of revision surgery for patients who need it.
Read the Bloomberg Businessweek report on the lawsuit.
Read other coverage on metal-on-metal hip replacements:
- Study: Metal-on-Metal Hip Replacement Could Have Long-Term Satisfactory Results
- DePuy Orthopaedics Recalls ASR Hip Systems
- Survey: 25% of Orthopedists Plan to Reduce Metal-on-Metal Hip Usage
The hip replacement system was recalled on Aug. 26, 2010 after it was found that the metal-on-metal hip replacements didn't work properly. U.S. District Judge David A. Katz in an Ohio federal court will supervise the evidence-gathering efforts. About 150 federal lawsuits are pending and will be consolidated to promote efficient conduct of litigation, according to the report.
DePuy recalled the ASR XL Acetabular System, a total hip-replacement product, and the DePuy ASR Hip Resurfacing System, which wasn't used in the U.S. Approximately 37,000 ASR implants were implanted in the United States. Researchers in the United Kingdom found that after five years, 13 percent of the patients with complete hip replacements and 12 percent of the patients with resurfacing devices needed a revision.
In a statement released by DePuy, the company will cover reasonable and customary costs of revision surgery for patients who need it.
Read the Bloomberg Businessweek report on the lawsuit.
Read other coverage on metal-on-metal hip replacements:
- Study: Metal-on-Metal Hip Replacement Could Have Long-Term Satisfactory Results
- DePuy Orthopaedics Recalls ASR Hip Systems
- Survey: 25% of Orthopedists Plan to Reduce Metal-on-Metal Hip Usage